Price
No data yet.
Social Signal Score
Analyst Ratings
3 analystsRevenue
$28.14M+1896.18%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Seth D. Yon
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 108
- Beta
- 1.16
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 3.89
Financials
Revenue
$28.14M+1896.2%Net Income
$-452.9K-349.5%EBITDA
$2.02M+772.1%Free Cash Flow
$2.03M+652.6%EPS (diluted)
$-0.05-151.0%Shares Outstanding (diluted)
8.66M+698.1%Operating Expenses
$23.76MCash & Debt
$15.42MReturn of Capital
$128.5KRevenue by Segment (annual)
$201.0KDividend per Share
$33.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $103.12M | $-37.56M | $-4.36 |
| 2024 | $86.67M | $-9.66M | $-1.14 |
| 2023 | $64.99M | $-4.30M | $-0.52 |
| 2022 | $45.84M | $-7.94M | $-1.00 |
| 2021 | $24.14M | $-7.92M | $-1.08 |
| 2020 | $15.59M | $-4.36M | $-0.76 |
| 2019 | $11.77M | $-2.81M | $-1.37 |
| 2018 | $5.84M | $-600.6K | $-0.28 |
| 2017 | $6.30M | $331.3K | $0.17 |
| 2016 | $5.51M | $-415.7K | $-0.38 |
| 2015 | $3.37M | $-1.34M | $-1.26 |
| 2014 | $2.63M | $-2.28M | $-2.16 |
| 2013 | $1.73M | $-4.15M | $-4.84 |
| 2012 | $1.17M | $-1.85M | $-2.68 |
Valuation
SMTIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+11.11%Social Signal Score
Mentions (4)
- Newsgurufocus.com·38d ago·Neutral
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Sanara MedTech Inc. (NASDAQ: SMTI) to MiMedx Group, Inc. for $33.00 in cash and 0.47
View source ↗ - Newsbusinesswire.com·38d ago·Neutral
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Sanara MedTech Inc. (NASDAQ: SMTI) to MiMedx Group, Inc. for $33.00 in cash and 0.4735 shares of MiMedx common stock for each share of Sanara common stock.Halper Sadeh encourages Sanara shareholders to click here to learn more about their rights and options or contact D…
View source ↗ - Newszacks.com·55d ago·Neutral
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates Sanara MedTech Inc. (SMTI) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.23 per share a year ago.
View source ↗ - Newsglobenewswire.com·55d ago·Negative
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported its financial results for the second quarter ended June 30, 2026.
View source ↗
Earnings
Wed, Nov 11(in 5 weeks)
Consensus estimate $0.06 per share
Typical surprise +5.3% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 11$-0.05 vs $-0.03miss
- Mon, May 11$0.04 vs $-0.04beat
- Tue, Mar 24$0.04 vs $0.11miss
- Wed, Nov 12$0.09 vs $-0.24beat
- Wed, Aug 13$-0.23 vs $-0.33beat
- Wed, May 14$-0.41 vs $-0.31miss
Estimates and results for SMTI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by SMTI officers and directors.
- Bought
- —
- Sold
- $32k
0 trades
2 trades
- Fleming Zachary B.sold
- Fleming Zachary B.sold
98 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in SMTI.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.